Call for papers: Current Controversies in the Medical Treatment of Early Breast Cancer
Systemic treatment for early breast has rapidly evolved in recent years, leading to new uncertainties regarding the sequence and combination of neoadjuvant and adjuvant therapies. We review in this special issue of the journal the most relevant clinical controversies and potential future advances in this setting.
Upcoming content:
- Can we use genomic tests before surgery to guide neoadjuvant systemic treatment of early breast cancer?
- When might endocrine-based neoadjuvant treatment be used in early luminal breast cancer?
- Should we modify the adjuvant systemic treatment in lobular breast cancer?
- Can we use Her2Dx to modulate treatment intensity in her2 positive early breast cancer?
- Is the addition of immunotherapy justified for all patients with triple negative breast cancer undergoing neoadjuvant treatment?
- How can we integrate current adjuvant treatment options for triple negative breast cancer patients with residual disease after neoadjuvant therapy?- Is pregnancy safe after breast cancer?
Guest editor:
Francisco Ayala de la Peña, MD, PhD
University of Murcia, Murcia, Spain
Special issue information:
The Special Issue welcomes reviews on clinical controversies related to medical treatment of early breast cancer.
Manuscript submission information:
The Revista de Senología y Patología Mamaria’s submission system is open for submissions to our Special Issue.
When submitting your manuscript please select the article type VSI: Med Oncol EBC from the drop-down list.
The deadline to submit the manuscript will be 31st May 2025.
All submissions deemed suitable to be sent for peer review will be reviewed by at least two independent reviewers. Once your manuscript is accepted, it will go into production, and will be simultaneously published in the current regular issue and pulled into the online Special Issue.
Articles from this Special Issue will appear in different regular issues of the journal, though they will be clearly marked and branded as Special Issue articles.
Please see an example here Science of the Total Environment
Please ensure you read the Guide for Authors before writing your manuscript. The Guide for Authors and link to submit your manuscript is available on the Journal’s homepage at Revista de Senología y Patología Mamaria.
Keywords:
Early breast cancer, Adjuvant, Neoadjuvant, Controversies, Systemic therapy, Endocrine therapy, Chemotherapy, Immunotherapy
Learn more about the benefits of publishing in a special issue.
Interested in becoming a guest editor? Discover the benefits of guest editing a special issue and the valuable contribution that you can make to your field.
- Call for papers
- Instructions for authors
- Submit an article
- Ethics in publishing
- Open Access Option
- Language Editing services
Artificial intelligence applied to medicine and particularly to breast disease grow rapidly. We review the current knowledge in this regard and point out the needs and future lines in this field.